[HTML][HTML] The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones

J Li, J Soroka, J Buchner - Biochimica et Biophysica Acta (BBA)-Molecular …, 2012 - Elsevier
Hsp90 is a dimeric molecular chaperone required for the activation and stabilization of
numerous client proteins many of which are involved in essential cellular processes like …

CFTR modulators: shedding light on precision medicine for cystic fibrosis

M Lopes-Pacheco - Frontiers in pharmacology, 2016 - frontiersin.org
Cystic fibrosis (CF) is the most common life-threatening monogenic disease afflicting
Caucasian people. It affects the respiratory, gastrointestinal, glandular and reproductive …

Emerging therapeutic approaches for cystic fibrosis. From gene editing to personalized medicine

I Pranke, A Golec, A Hinzpeter, A Edelman… - Frontiers in …, 2019 - frontiersin.org
An improved understanding of the cystic fibrosis (CF) transmembrane conductance regulator
(CFTR) protein structure and the consequences of CFTR gene mutations have allowed the …

Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease

P Anand, JS Stamler - Journal of molecular medicine, 2012 - Springer
Nitric oxide participates in cellular signal transduction largely through S-nitrosylation of
allosteric and active-site cysteine thiols within proteins, forming S-nitroso-proteins (SNO …

New and emerging targeted therapies for cystic fibrosis

BS Quon, SM Rowe - Bmj, 2016 - bmj.com
Cystic fibrosis (CF) is a monogenic autosomal recessive disorder that affects about 70 000
people worldwide. The clinical manifestations of the disease are caused by defects in the …

Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration

T Nakamura, C Oh, X Zhang, SA Lipton - Free Radical Biology and …, 2021 - Elsevier
Neurodegenerative disorders like Alzheimer's disease and Parkinson's disease are
characterized by progressive degeneration of synapses and neurons. Accumulation of …

Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy

J Franke, S Eichner, C Zeilinger, A Kirschning - Natural product reports, 2013 - pubs.rsc.org
Covering: 2005 to 2013In this review recent progress in the development of heat shock
proteins (Hsp90) in oncogenesis is illuminated. Particular emphasis is put on inhibitors such …

CFTR Folding: From Structure and Proteostasis to Cystic Fibrosis Personalized Medicine

EF McDonald, J Meiler, L Plate - ACS Chemical Biology, 2023 - ACS Publications
Cystic fibrosis (CF) is a lethal genetic disease caused by mutations in the chloride ion
channel cystic fibrosis transmembrane conductance regulator (CFTR). Class-II mutants of …

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives

BZ Schmidt, JB Haaf, T Leal, S Noel - … : advances and applications, 2016 - Taylor & Francis
Mutations of the CFTR gene cause cystic fibrosis (CF), the most common recessive
monogenic disease worldwide. These mutations alter the synthesis, processing, function, or …

Strategies for the etiological therapy of cystic fibrosis

L Maiuri, V Raia, G Kroemer - Cell Death & Differentiation, 2017 - nature.com
Etiological therapies aim at repairing the underlying cause of cystic fibrosis (CF), which is
the functional defect of the cystic fibrosis transmembrane conductance regulator (CFTR) …